Biblio
Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
(2019). (2019). Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL-mutation.Eur J Haematol.
(2019). Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.Bone Marrow Transplant.
(2019). Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis.Biol Blood Marrow Transplant.
(2019). Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
(2019). Induction, bridging or straight ahead the ongoing dilemma of allografting in advanced MDS.Biol Blood Marrow Transplant.
(2019). (2019). (2019). ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF.Leukemia.
(2018). Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT.Biol Blood Marrow Transplant.
(2018). HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis.Biol Blood Marrow Transplant.
(2018). (2018). Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med374, 43-53.
(2016). (2016). Outcome after transplantation according to reduced intensity conditioning regimen in patients transplanted for myelofibrosis.Biol Blood Marrow Transplant.
(2016). (2016). (2016). (2016). (2016). (2015). (2015).
Digital PCR to assess haematopoietic chimaerism after allogeneic stem cell transplantation.Exp Hematol.
(2015). (2015). (2015).